Sign In

Mha Kevin Wang

Senior Director, Performance Programs at Hospital for Special Surgery

Kevin Wang, MHA, is a dedicated healthcare management professional with a strong passion for leveraging process engineering, digital technology, and project management to enhance the accessibility, user-friendliness, and reliability of healthcare services. His primary goal is to assist healthcare providers in delivering top-tier care through transformative enhancements while also focusing on improving health systems globally. Outside of work, Kevin enjoys activities like cycling, running, and savoring espresso.

Kevin holds an impressive educational background, having completed a Master of Healthcare Administration degree at Columbia University Mailman School of Public Health, a B.A in Public Health Studies from The Johns Hopkins University, an IB Diploma from the International School of Beijing, and a Doctor of Public Health (DrPH) in Health Policy & Management specializing in Quality & Patient Safety from Johns Hopkins Bloomberg School of Public Health.

With a wealth of experience, Kevin has held key roles in various prestigious organizations, including his current position as Senior Director of Performance Programs at the Hospital for Special Surgery. Previously, he served as the Director of Quality & Value and Quality Officer at Columbia University Irving Medical Center, as well as a Quality, Safety, Value Fellow at the same institution. His healthcare journey also includes roles as an Administrative Intern at New Century Women's and Children's Hospital, a Patient Safety Intern at the World Health Organization, and a Research Assistant at Johns Hopkins Hospital. Kevin's diverse professional background also encompasses positions such as a Medical Archivist at Johns Hopkins School of Medicine and an Administrative & Marketing Intern at Beijing United Family Hospital and Clinics.

Highlights

Jan 27 · twitter

Some more thoughts on Garner Health's white paper from the other day. I wanted to dive deeper into why costs increase with transparency and how specialty drugs are driving up costs for employers. https://t.co/WpQQY1dK3E

Some more thoughts on Garner Health's white paper  from the other day. I wanted to dive deeper into
Jan 27 · twitter

We’re getting into an interesting space where wearable device cos can actually tell us something actionable and useful. Paired that with the fact that in China costs for CGMs are getting so low ($15/pop) and you have exciting access to true preventative health.

Mha Kevin Wang
Add to my network

Location

New York, New York